Centre for Commercialization of Regenerative Medicine

Printer-friendly versionSend to friend

Welcome

CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies. CCRM is supported by the Centres of Excellence for Commercialization and Research (CECR) Program.

Events List

Workshops Register Now

Science, Industry & Business News

May 15/12 Stem cell co Gamida Cell raises $10M with partner Teva Pharmaceuticals.
May 14/12 Tissue regeneration co Regentis Biomaterials raises $10M.
May 12/12 Celgene announces three phase III Revlimid trials in newly diagnosed MM patients.
May 10/12 Study identifies cell subtypes for potential personalized cellular therapies.
May 9/12 Two cell transplantation studies impact dental stem cell research for therapeutic purposes.
May 4/12 New muscular dystrophy treatment approach developed using human stem cells.
May 4/12 UCLA stem cell research may help patients with neuromuscular disorders.
May 4/12 Royal DSM to acquire biomaterials R&D leader Kensey Nash.
May 3/12 Taiwan, EU promote biomaterial collaboration.
Apr 26/12 From embryonic stem cells, a sperm replacement and easier path to genetic modification.